CASEY BUNCHER: Open Payments
NPI 1891336178 · UNION, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 41 payments from 19 companies in 2025. Trend: 2023 $629 · 2024 $746 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $148 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 2 | $72 |
| Exact Sciences Corporation | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Tris Pharma Inc | 2 | $35 |
Products named: REXULTI, Jornay PM, VOQUEZNA, Wegovy, Ozempic, JARDIANCE, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across MO — which companies pay providers there.
